RPID — Rapid Micro Biosystems Share Price
Last trade - 00:00- $32.65m
- $32.19m
- $33.59m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.84 | ||
| Price to Tang. Book | 1.84 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.93 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -123.47% | ||
| Return on Equity | -141.65% | ||
| Operating Margin | -141.45% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 23.23 | 17.13 | 22.52 | 28.05 | 33.59 | 39.42 | 45.65 | 15.88% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Rapid Micro Biosystems, Inc. is an innovative life sciences technology company that enables the safe manufacture of pharmaceutical products through its rapid automated microbial quality control (MQC) detection platform. The Company develops, manufactures, markets and sells the Growth Direct system and related proprietary consumables, and value-added services to enable rapid MQC testing in the manufacture of biologics and cell and gene therapies, vaccines, sterile injectables, and other healthcare products. Its Growth Direct platform comprises the Growth Direct system, optional laboratory information management system (LIMS) connection software, proprietary consumables, and comprehensive field service, validation services and post-warranty service contracts. Its technology fully automates and digitizes the process of pharmaceutical MQC and is designed to enable its customers to perform this critical testing process accurately and securely.
Directors
- Richard Kollender IND (56)
- Robert Spignesi PRE (57)
- Sean Wirtjes CFO (56)
- Melinda Litherland IND (68)
- Inese Lowenstein IND (53)
- Kirk Malloy NEC (59)
- Dafni Bika IND (61)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- December 29th, 2006
- Public Since
- July 15th, 2021
- No. of Employees
- 171
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 50,159,556
- Address
- 1001 Pawtucket Blvd West, Suite 280, LOWELL, 01854
- Web
- https://www.rapidmicrobio.com/
- Phone
- +1 9783493200
- Auditors
- PricewaterhouseCoopers LLP
Latest News for RPID
Upcoming Events for RPID
Q4 2026 Rapid Micro Biosystems Inc Earnings Release
Similar to RPID
20/20 BIOLABS
NASDAQ Capital Market
Accuray Incorporated
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
AdaptHealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
FAQ
As of Today at 12:53 UTC, shares in Rapid Micro Biosystems are trading at $0.65. This share price information is delayed by 15 minutes.
Shares in Rapid Micro Biosystems last closed at $0.65 and the price had moved by -85.4% over the past 365 days. In terms of relative price strength the Rapid Micro Biosystems share price has underperformed the S&P500 Index by -87% over the past year.
The overall consensus recommendation for Rapid Micro Biosystems is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreRapid Micro Biosystems does not currently pay a dividend.
Rapid Micro Biosystems does not currently pay a dividend.
Rapid Micro Biosystems does not currently pay a dividend.
To buy shares in Rapid Micro Biosystems you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.65, shares in Rapid Micro Biosystems had a market capitalisation of $32.65m.
Here are the trading details for Rapid Micro Biosystems:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: RPID
Based on an overall assessment of its quality, value and momentum Rapid Micro Biosystems is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Rapid Micro Biosystems is $6.00. That is 821.66% above the last closing price of $0.65.
Analysts covering Rapid Micro Biosystems currently have a consensus Earnings Per Share (EPS) forecast of -$0.94 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Rapid Micro Biosystems. Over the past six months, its share price has underperformed the S&P500 Index by -69.21%.
As of the last closing price of $0.65, shares in Rapid Micro Biosystems were trading -68.39% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Rapid Micro Biosystems PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.65.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Rapid Micro Biosystems' management team is headed by:
- Richard Kollender - IND
- Robert Spignesi - PRE
- Sean Wirtjes - CFO
- Melinda Litherland - IND
- Inese Lowenstein - IND
- Kirk Malloy - NEC
- Dafni Bika - IND